Eloxx Pharmaceuticals names T.R. Srinivas chief medical officer
ELOX•Eloxx Pharmaceuticals appointed T.R. Srinivas as senior vice president and chief medical officer in October 2026. Geno Germano joined the board effective October 19, 2026.
1. Leadership appointments
Eloxx Pharmaceuticals appointed a former Novartis U.S. medical affairs leader as senior vice president and chief medical officer in October 2026. Geno Germano joined the board effective October 19; he most recently served as president and chief executive officer of Elucida Oncology and has more than 35 years of biopharmaceutical leadership experience.



